AccessPak for HIV PEP Expanded with Kaletra and Tisagenlecleucel
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Tisagenlecleucel and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: tisagenlecleucel
Brand name: Kymriah
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Tisagenlecleucel Intravenous
- AccessPak for HIV PEP Expanded with Kaletra-Titralac
- AccessPak for HIV PEP Expanded with Kaletra-Tivicay
- AccessPak for HIV PEP Expanded with Kaletra-Tivicay (Dolutegravir 10 mg)
- AccessPak for HIV PEP Expanded with Kaletra-Tivicay (Dolutegravir 25 mg and 50 mg)
- AccessPak for HIV PEP Expanded with Kaletra-Tivorbex
- Tisagenlecleucel-AccessPak for HIV PEP Expanded with Viracept
- Tisagenlecleucel-Accolate
- Tisagenlecleucel-Accretropin
- Tisagenlecleucel-Accucaine
- Tisagenlecleucel-AccuHist Drops
- Tisagenlecleucel-AccuHist PDX Drops